Citation: | XIAO Yuanyuan, HOU Mengling, HE Shenghu. Preliminary study on the changes of residual lipoprotein-cholesterol after three meals in patients with coronary heart disease[J]. Journal of Clinical Medicine in Practice, 2019, 23(7): 6-11. DOI: 10.7619/jcmp.201907003 |
[1] |
Sandesara P B, Virani S S, Fazio S, et al. The forgotten lipids: triglycerides, remnant cholesterol, and atherosclerotic cardiovascular disease risk[J]. Endocr Rev, 2019, 40(2): 537-557. doi: 10.1210/er.2018-00184
|
[2] |
Varbo A, Nordestgaard B G. Remnant cholesterol and ischemic heart disease[J]. Curr Opin Lipidol, 2014, 25(4): 266-273. doi: 10.1097/MOL.0000000000000093
|
[3] |
Rosenson R S, Davidson M H, Hirsh B J, et al. Genetics and causality of triglyceride-rich lipoproteins in atherosclerotic cardiovascular disease[J]. J Am Coll Cardiol, 2014, 64(23): 2525-2540. doi: 10.1016/j.jacc.2014.09.042
|
[4] |
Hong L F, Yan X N, Lu Z H, et al. Predictive value of non-fasting remnant cholesterol for short-term outcome of diabetics with new-onset stable coronary artery disease[J]. Lipids Health Dis, 2017, 16(1): 7-16. doi: 10.1186/s12944-017-0410-0
|
[5] |
Bansal S, Buring J E, Rifai N, et al. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women[J]. JAMA, 2007, 298(3): 309-316. doi: 10.1001/jama.298.3.309
|
[6] |
刘玲, 赵水平, 程艳春, 等. 检测高脂餐后高甘油三酯血症的最佳时间切点[J]. 中华内分泌代谢杂志, 2004, 20(1): 23-25. doi: 10.3760/j.issn:1000-6699.2004.01.010
|
[7] |
Varbo A, Benn M, Tybjærg-Hansen A, et al. Remnant cholesterol as a causal risk factor for ischemic heart disease[J]. J Am Coll Cardiol, 2013, 61(4): 427-436. doi: 10.1016/j.jacc.2012.08.1026
|
[8] |
Varbo A, Benn M, Tybjærg-Hansen A, et al. Elevated remnant cholesterol causes both low-grade inflammation and ischemic heart disease, whereas elevated low-density lipoprotein cholesterol causes ischemic heart disease without inflammation[J]. Circulation, 2013, 128(12): 1298-1309. doi: 10.1161/CIRCULATIONAHA.113.003008
|
[9] |
Cully M. Lipids: Remnant cholesterol is associated with ischaemic heart disease[J]. Nat Rev Cardiol, 2013, 10(3): 119-128. http://www.nature.com/articles/nrcardio.2013.3
|
[10] |
Varbo A, Benn M, Nordestgaard B G. Remnant cholesterol as a cause of ischemic heart disease: evidence, definition, measurement, atherogenicity, high risk patients, and present and future treatment[J]. Pharmacol Ther, 2014, 141(3): 358-367. doi: 10.1016/j.pharmthera.2013.11.008
|
[11] |
Boekholdt S M, Hovingh G K, Mora S, et al. Very low levels of atherogenic lipoproteins and the risk for cardiovascular events: a meta-analysis of statin trials[J]. J Am Coll Cardiol, 2014, 64(5): 485-494. doi: 10.1016/j.jacc.2014.02.615
|
[12] |
Tada H, Kawashiri M A, Nohara A, et al. Remnant-like particles and coronary artery disease in familial hypercholesterolemia[J]. Clin Chim Acta, 2018, 482: 120-123. doi: 10.1016/j.cca.2018.04.007
|
[13] |
Pastori D, Baratta F, Novo M, et al. Remnant lipoprotein cholesterol and cardiovascular and cerebrovascular events in patients with non-alcoholic fatty liver disease[J]. J Clin Med, 2018, 7(11): E378-E381. doi: 10.3390/jcm7110378
|
[14] |
Kikuchi K, Nezu U, Inazumi K, et al. Double-blind randomized clinical trial of the effects of ezetimibe on postprandial hyperlipidaemia and hyperglycaemia[J]. J Atheroscler Thromb, 2012, 19(12): 1093-1101. doi: 10.5551/jat.12427
|
[15] |
Scharnagl H, Kleber M E, Mürz W. Letter by Scharnagl et al regarding article, "Elevated remnant cholesterol causes both low-grade inflammation and ischemic heart disease, whereas elevated low-density lipoprotein cholesterol causes ischemic heart disease without inflammation"[J]. Circulation, 2014, 129(24): e654-e659. doi: 10.1161/circulationaha.113.006433
|
[16] |
Jones S R, Martin S S, Brinton E A. Letter by Jones et al regarding article, "Elevated remnant cholesterol causes both low-grade inflammation and ischemic heart disease, whereas elevated low-density lipoprotein cholesterol causes ischemic heart disease without inflammation"[J]. Circulation, 2014, 129(24): e655-e661. http://www.tandfonline.com/servlet/linkout?suffix=CIT0094&dbid=8&doi=10.1080%2F02682621.2018.1493640&key=23926208
|
[17] |
Nakajima K, Saito T, Tamura A, et al. Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apo B-100 and anti apo A-I immunoaffinity mixed gels[J]. Clin Chim Acta, 1993, 223(1/2): 53-71. http://www.sciencedirect.com/science/article/pii/0009898193900629
|
[18] |
Miyauchi K, Kayahara N, Ishigami M, et al. Development of a homogeneous assay to measure remnant lipoprotein cholesterol[J]. Clin Chem, 2007, 53(12): 2128-2135. doi: 10.1373/clinchem.2007.092296
|
[19] |
Friedewald W T, Levy R I, Fredrickson D S. Estimation of the concentration of low-density lipoprotein cholesterol in serum, without use of the preparative ultracentrifuge[J]. Clinical chemistry, 1972, 18(6): 499-502. doi: 10.1093/clinchem/18.6.499
|